Senior insider sale
Chief Executive Officer at PYXIS ONCOLOGY, INC. — senior position signals high conviction
$81.5K
36.56K shares
What this filing means
SULLIVAN LARA plans to sell 36.56K shares of PYXIS ONCOLOGY, INC. valued at approximately $81.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/18/2023ACC: 0001959173-23-003986
DirectorOfficer· Chief Executive Officer
Since Oct 2021
36.56K
Shares to sell
$81.5K
Approx. market value
8.54K
Acquired (3 months)
1
Planned
4 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
3/31/2023
8.54KTotal acquired8.54K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/31/2023 | Restricted Stock Vesting Compensation | 8.54K | — |
| Total | 8.54K | ||
Planned & Completed Dispositions5
Completed
—Completed
Units to sell
100.00
Market value
$225.00
9/14/2023
—Completed
Units to sell
3K
Market value
$6.8K
9/13/2023
—Completed
Units to sell
4.92K
Market value
$11.1K
9/12/2023
—Completed
Units to sell
20K
Market value
$45.4K
9/11/2023
Planned — Approximate Date
NASDAQPlanned
Units to sell
8.54K
Market value
$17.9K
9/18/2023
Total
Units
36.56K
Value
$81.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/14/2023 | 100.00 | $225.00 | — | Completed |
9/13/2023 | 3K | $6.8K | — | Completed |
9/12/2023 | 4.92K | $11.1K | — | Completed |
9/11/2023 | 20K | $45.4K | — | Completed |
| Planned — Approximate Date | ||||
9/18/2023 | 8.54K | $17.9K | NASDAQ | Planned |
| Total | 36.56K | $81.5K | ||